Navigation Links
Ludlow Research Issues Opinion on PMBS Based on Low Market Cap Valuation
Date:4/24/2013

SCHOFIELD, Wis., April 24, 2013 /PRNewswire/ -- PuraMed BioScience®, Inc., (PMBS: OTCBB), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced that Ludlow Research had issued a research opinion on the company and its flagship product, LipiGesic® M.
 
Report Highlights

- Non-Prescription Product to Treat Migraine Headaches
- Product Shown to Outperform #1 Prescription Competitor
- Holds Patent on Product
- Product Currently Available Walgreen's and CVS/pharmacy stores Nationwide
- Expanding Retail Chain-Store Distribution
- Launching Marketing and Distribution Campaign
- 34 Million Shares Outstanding
- Market Cap just under $1 Million

PuraMed has contracted both bulk manufacturing and packaging firms to assist in the planned national expansion of LipiGesic M, their over-the-counter migraine relief product. The Company commented that they had selected Hillestad Pharmaceuticals as their fully licensed OTC drug manufacturer, with both Unette Corporation and Proteus Packaging to assist in packaging of products for store shelves.
 
This comes on the heels of news that their over-the-counter migraine pain reliever product was currently in Walgreen's and CVS/pharmacy stores nationwide, and PuraMed BioScience plans to expand that retail placement to an additional 21,000 targeted retail outlets, including mass merchandisers such as Wal-Mart and Target; food-store chains such as SuperValu, Kroger, and Safeway; as well as regional drugstore chains.

Current Valuation
Based on current and planned distribution to some of the nation's largest retail drug chains, and having the infrastructure to fulfill orders, PMBS now has all the pieces in place to expand product sales. With just around 34 million common shares outstanding, and a market cap valuation of around $850,000 Ludlow Research feels there could be some good speculative upside potential.

To view the full report, and access risks, disclosures, and potential outlook visit http://www.wallstreetnewscast.com/profile/pmbs.html

About PuraMed BioScience, Inc.
PuraMed BioScience engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to LipiGesic M, PuraMed BioScience plans to launch LipiGesic H for tension-type headaches and LipiGesic PM, which provides a remedy for insomnia and other sleep disorders. www.puramedbioscience.com

Forward-Looking Statements
This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties that may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact:
Melissa Diaz ,
South Street Media, Inc
Phone: (917) 937-8968
Email: info@southstreetmedia.com


'/>"/>
SOURCE PuraMed BioScience, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Musculoskeletal Network covers the Osteoarthritis Research Society International Conference
2. Nephrology & Urology Devices Market is Expected to Reach USD 20.5 Billion Globally in 2018: Transparency Market Research
3. Express Scripts Research Shows Prescription Drug Utilization Declines for Payers of Workers Compensation
4. Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy Adds The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
5. X-Ray Market (Portable, Handheld, Digital Radiography, Computed Radiography, Flat Panel Detection Systems, Mammography) is Expected to Reach USD 9.8 Billion Globally in 2018: Transparency Market Research
6. Serina Therapeutics Announces Worldwide Exclusive License Agreement with The Scripps Research Institute for Click Chemistry
7. Mast Therapeutics Presents MST-188 Data at 7Th Annual Sickle Cell Disease Research and Educational Symposium
8. Global Medical Robotic Systems Market is Expected to Reach USD 13.64 Billion by 2018: Transparency Market Research
9. Breast Pumps Market Is Expected to Reach USD 1.03 Billion Globally in 2018: Transparency Market Research
10. Jeffrey Epstein, New York Philanthropist, Funds Pioneering Cancer Metastasis Research at Mount Sinai
11. New Research Reveals Link between Marijuana and Inappropriate Use of Pain Medications, other Prescription Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... , August 17, 2017 DarioHealth Corp. ... with mobile health and big data solutions, announced ... with domestic and non-U.S. investors for the sale ... shares of the Company,s newly designated Series B ... The Company expects to conduct a closing with ...
(Date:8/15/2017)... Pharmaceuticals Inc., the creator of the drug Truveta for the ... an IPO. The United States spends ... a prescription epilepsy drug being $450.00-$1200.00 for a one month supply. ... AXIUM PHARMACEUTICALS, INC ... figure is the fact that Americans spent $42 billion on anxiety medications ...
(Date:8/11/2017)... , Aug. 11, 2017 DarioHealth Corp. ... mobile health and big data solutions, today announced that ... Monday, August 14 and host a conference call at ... 2017 operating and financial results and its strategy and ... be hosted by Erez Raphael , Chief Executive ...
Breaking Medicine Technology:
(Date:8/19/2017)... (PRWEB) , ... August 19, 2017 , ... Yesterday, the ... KKK by saying there are two sides. There are not two sides to hatred, ... to rationalize violence and prejudice, and the NPEIV stands against all forms of such ...
(Date:8/19/2017)... (PRWEB) , ... August 19, 2017 , ... “Congratulations! It's ... value of children to both their parents and God. “Congratulations! It's A Boy! God’s ... Rachael Anthony, a couple from Long Island, New York. , Published by Christian Faith ...
(Date:8/18/2017)... ... ... ... For Immediate Release                Contact: Julian Teixeira, August ... Seek Sex and Relationship Advice from their Fathers , ...
(Date:8/18/2017)... NY (PRWEB) , ... August 18, 2017 , ... ... of this summer’s edition of “Vision & Hearing,” advocating for active, healthy lifestyles ... focuses on resources available for individuals with hearing impairments and shares the latest ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... The Dawn ... is inaugurating a new charity drive to generate community support for efforts to educate ... into cures and treatments for all types of cancer. , Each day in ...
Breaking Medicine News(10 mins):